Literature DB >> 22318127

Expression and activation of EphA4 in the human brain after traumatic injury.

Tony Frugier1, Alison Conquest, Catriona McLean, Peter Currie, David Moses, Yona Goldshmit.   

Abstract

Glial scars that consist predominantly of reactive astrocytes create a major barrier to neuronal regeneration after traumatic brain injury (TBI). In experimental TBI, Eph receptors and their ephrin ligands are upregulated on reactive astrocytes at injury sites and inhibit axonal regeneration, but very little is known about Eph receptors in the human brain after TBI. A better understanding of the functions of glial cells and their interactions with inflammatory cells and injured axons will allow the development of treatment strategies that may promote regeneration. We analyzed EphA4 expression and activation in postmortem brain tissue from 19 patients who died after acute closed head injury and had evidence of diffuse axonal injury and 8 controls. We also examined downstream pathways that are mediated by EphA4 in human astrocyte cell cultures. Our results indicate that, after TBI in humans, EphA4 expression is upregulated and is associated with reactive astrocytes. The expression was increased shortly after the injury and remained activated for several days. EphA4 activation induced under inflammatory conditions in vitro was inhibited using unclustered EphA4 ligand. These results suggest that blocking EphA4 activation may represent a therapeutic approach for TBI and other types of brain injuries in humans.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22318127     DOI: 10.1097/NEN.0b013e3182496149

Source DB:  PubMed          Journal:  J Neuropathol Exp Neurol        ISSN: 0022-3069            Impact factor:   3.685


  24 in total

Review 1.  Therapeutic targeting of EPH receptors and their ligands.

Authors:  Andrew W Boyd; Perry F Bartlett; Martin Lackmann
Journal:  Nat Rev Drug Discov       Date:  2014-01       Impact factor: 84.694

2.  Neuronal adhesion and synapse organization in recovery after brain injury.

Authors:  Kellie Park; Thomas Biederer
Journal:  Future Neurol       Date:  2013-09

Review 3.  Ephs and Ephrins in malignant gliomas.

Authors:  Sara Ferluga; Waldemar Debinski
Journal:  Growth Factors       Date:  2014-11-24       Impact factor: 2.511

4.  Regulation of ephrin-A expression in compressed retinocollicular maps.

Authors:  Tizeta Tadesse; Qi Cheng; Mei Xu; Deborah J Baro; Larry J Young; Sarah L Pallas
Journal:  Dev Neurobiol       Date:  2012-11-28       Impact factor: 3.964

5.  Calcineurin proteolysis in astrocytes: Implications for impaired synaptic function.

Authors:  Melanie M Pleiss; Pradoldej Sompol; Susan D Kraner; Hafiz Mohmmad Abdul; Jennifer L Furman; Rodney P Guttmann; Donna M Wilcock; Peter T Nelson; Christopher M Norris
Journal:  Biochim Biophys Acta       Date:  2016-05-20

6.  Activation of the kynurenine pathway and increased production of the excitotoxin quinolinic acid following traumatic brain injury in humans.

Authors:  Edwin B Yan; Tony Frugier; Chai K Lim; Benjamin Heng; Gayathri Sundaram; May Tan; Jeffrey V Rosenfeld; David W Walker; Gilles J Guillemin; Maria Cristina Morganti-Kossmann
Journal:  J Neuroinflammation       Date:  2015-05-30       Impact factor: 8.322

7.  Military personnel with chronic symptoms following blast traumatic brain injury have differential expression of neuronal recovery and epidermal growth factor receptor genes.

Authors:  Morgan Heinzelmann; Swarnalatha Y Reddy; Louis M French; Dan Wang; Hyunhwa Lee; Taura Barr; Tristin Baxter; Vincent Mysliwiec; Jessica Gill
Journal:  Front Neurol       Date:  2014-10-09       Impact factor: 4.003

8.  Antisense-mediated reduction of EphA4 in the adult CNS does not improve the function of mice with amyotrophic lateral sclerosis.

Authors:  Karen K Ling; Michaela Jackson; Duah Alkam; Dawei Liu; Norm Allaire; Chao Sun; Mahmoud Kiaei; Alexander McCampbell; Frank Rigo
Journal:  Neurobiol Dis       Date:  2018-03-06       Impact factor: 5.996

9.  Blocking of bradykinin receptor B1 protects from focal closed head injury in mice by reducing axonal damage and astroglia activation.

Authors:  Christiane Albert-Weissenberger; Christian Stetter; Sven G Meuth; Kerstin Göbel; Michael Bader; Anna-Leena Sirén; Christoph Kleinschnitz
Journal:  J Cereb Blood Flow Metab       Date:  2012-05-09       Impact factor: 6.200

10.  NMR-Guided Design of Potent and Selective EphA4 Agonistic Ligands.

Authors:  Carlo Baggio; Anna Kulinich; Cassandra N Dennys; Rochelle Rodrigo; Kathrin Meyer; Iryna Ethell; Maurizio Pellecchia
Journal:  J Med Chem       Date:  2021-07-22       Impact factor: 8.039

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.